Artificial Intelligence (AI) is rapidly transforming the field of reproductive medicine by enhancing diagnostics, treatment planning, data interpretation, and clinical decision-making. The Artificial Intelligence SIG aims to foster collaboration and knowledge exchange among clinicians, scientists, embryologists, and data experts across the Asia-Pacific region.
Through education, research, and interdisciplinary dialogue, this SIG seeks to promote responsible, ethical, and innovative application of AI technologies to improve patient outcomes and advance reproductive healthcare.
Korea
Taiwan
Thailand
China
Korea
Singapore
India
Taiwan
Australia
India